Cancer-Focused Vivace Emerges with $40M in Financing

A cancer-focused drug discoverer and developer emerged from stealth mode by disclosing today that it has raised $40 million in Series A and Series B financings.

http://www.genengnews.com/gen-news-highlights/cancer-focused-vivace-emerges-with-40m-in-financing/81254586

4 Comments



4 Responses to Cancer-Focused Vivace Emerges with $40M in Financing

Leave a Reply

Your email address will not be published. Required fields are marked *